Time to act on the evil duo: treat tb, manage hiv and save lives

Journal Title: INTERNATIONAL JOURNAL OF CURRENT RESEARCH - Year 2014, Vol 6, Issue 1

Abstract

TB and HIV have been closely linked since the emergence of AIDS. This review paper aims to explore the double burden of TB-HIV worldwide, social impact of the epidemic, strategies being followed to control the epidemic and the challenges associated with TB-HIV control activities. An estimated one-third of the 40 million people living with HIV/AIDS (PLHIVs) worldwide are co-infected with TB. PLHIVs are also evaluated to be 15 times more likely to develop TB than HIV negative people. These two diseases represent a lethal combination since they are more destructive together and project challenges in both diagnosis and treatment, interactions between HIV and TB medications, and overlapping medication toxicities, Immune Reconstitution Inflammatory Syndrome (IRIS) and challenges related to adherence. As the HIV and TB services seem disconnected at present, they result in an increase in the cost of care for patients, higher losses to follow-up due to depression and stigma and delays in ART initiation. To combat the fuelling epidemic of HIV and TB globally, there is a need for a Zero parallel system for HIV and TB that must create coherence and synergy between the two programs and strengthen the mechanisms that would indicate effective control, interventions to improve quality of life and significant public health gains. There is a potential need to improve TB treatment outcomes and the contribution that TB-HIV collaboration can make. It also demands additional research to reduce spread of TB, pro-actively identify TB in PLHIVs and reduce mortality.

Authors and Affiliations

Dr. Himanshu Gupta and Dr. Sheetal Bishnoi

Keywords

Related Articles

Nanotechnology” - The New Era Of Prosthodontics

Cloude Levi Strauss and Winfred Phillips said that, “You have to be able to fabricate things, you have to be able to analyze things, and you have to be able to handle things smaller than ever imagined in ways not done be...

Comparison of efficacy of combination of proteolytic enzymes with diclofenac sodium versus diclofenac sodium alone in patients undergoing surgical extraction of moderately difficult impacted mandibular third molars

Objectives: Surgical extraction of impacted mandibular third molar in many cases leads to debilitating post-operative complications which are routinely managed with drugs like corticosteroids, NSAID’s and opiods. Unfort...

Role Of Selenium In Progress Of Cd4 Count

HIV infection is a global disease that disproportionately burdens populations with nutritional vulnerabilities. Selenium plays a key role in the maintenance of normal health in human population. It has been demonstrated...

Guidelines for integrative treatment of Parkinson disease

During the last decade, the use of traditional medicine has expanded globally and has gained popularity. It has not only continued to be used for primary health care of the poor in developing countries, but has also been...

Comparative evaluation of blood culture, estimation of immunoglobulin m (igm) and c-reactive protein (crp) detection in the diagnosis of neonatal sepsis

This clinical study was conducted to evaluate the diagnostic value of C-reactive protein (CRP), Immunoglobulin M (IgM) in the early diagnosis of neonatal sepsis. The diagnostic values of each marker separately or in comb...

Download PDF file
  • EP ID EP405936
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

Dr. Himanshu Gupta and Dr. Sheetal Bishnoi (2014). Time to act on the evil duo: treat tb, manage hiv and save lives. INTERNATIONAL JOURNAL OF CURRENT RESEARCH, 6(1), 4595-4600. https://europub.co.uk/articles/-A-405936